- Home
- SVII vs CYBN Comparison
SVII vs CYBN Comparison
Compare SVII & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVII
- CYBN
- Stock Information
- Founded
- SVII 2021
- CYBN 2019
- Country
- SVII United States
- CYBN Canada
- Employees
- SVII N/A
- CYBN N/A
- Industry
- SVII Blank Checks
- CYBN Pharmaceuticals and Biotechnology
- Sector
- SVII Finance
- CYBN Health Care
- Exchange
- SVII Nasdaq
- CYBN Nasdaq
- Market Cap
- SVII 252.5M
- CYBN 229.8M
- IPO Year
- SVII 2022
- CYBN N/A
- Fundamental
- Price
- SVII $11.23
- CYBN $10.19
- Analyst Decision
- SVII
- CYBN Strong Buy
- Analyst Count
- SVII 0
- CYBN 3
- Target Price
- SVII N/A
- CYBN $138.00
- AVG Volume (30 Days)
- SVII 134.4K
- CYBN 559.2K
- Earning Date
- SVII 01-01-0001
- CYBN 11-13-2024
- Dividend Yield
- SVII N/A
- CYBN N/A
- EPS Growth
- SVII N/A
- CYBN N/A
- EPS
- SVII N/A
- CYBN N/A
- Revenue
- SVII N/A
- CYBN N/A
- Revenue This Year
- SVII N/A
- CYBN N/A
- Revenue Next Year
- SVII N/A
- CYBN N/A
- P/E Ratio
- SVII $12.50
- CYBN N/A
- Revenue Growth
- SVII N/A
- CYBN N/A
- 52 Week Low
- SVII $10.78
- CYBN $6.50
- 52 Week High
- SVII $11.70
- CYBN $21.66
- Technical
- Relative Strength Index (RSI)
- SVII 34.95
- CYBN 47.03
- Support Level
- SVII $11.20
- CYBN $10.36
- Resistance Level
- SVII $11.37
- CYBN $13.88
- Average True Range (ATR)
- SVII 0.05
- CYBN 1.32
- MACD
- SVII -0.04
- CYBN -0.08
- Stochastic Oscillator
- SVII 6.00
- CYBN 8.40
About SVII Spring Valley Acquisition Corp. II
Spring Valley Acquisition Corp II is a blank check company.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.